Skip to content

    Schizophrenia Health Center

    Font Size
    A
    A
    A

    New Drug for Schizophrenia, Major Depression

    Medication can be used as an add-on therapy to antidepressants

    WebMD News from HealthDay

    By Robert Preidt

    HealthDay Reporter

    MONDAY, July 13, 2015 (HealthDay News) -- A new drug to treat schizophrenia and depression has been approved by the U.S. Food and Drug Administration.

    Rexulti (brexpiprazole) tablets can be used to treat adults with schizophrenia. The new drug can also be used as an add-on therapy to antidepressant drugs for adults with major depression.

    "Schizophrenia and major depressive disorder can be disabling and can greatly disrupt day-to-day activities," Dr. Mitchell Mathis, director of the Division of Psychiatry Products in the FDA's Center for Drug Evaluation and Research, said in an agency news release.

    "Medications affect everyone differently so it is important to have a variety of treatment options available for patients with mental illnesses," he added.

    The FDA's approval of Rexulti for treatment of schizophrenia is based on two six-week clinical trials with more than 1,300 people. People taking the drug had fewer symptoms of schizophrenia than those who took a placebo, the studies found.

    Rexulti was also tested as an add-on therapy for major depression. For this treatment, researchers conducted two six-week clinical trials. The trials included more than 1,000 patients whose symptoms were not adequately treated by taking an antidepressant alone. Those who took Rexulti and an antidepressant had fewer symptoms of depression than those who took a placebo and an antidepressant, the FDA said.

    Weight gain and a sense of restlessness were the most common side effects reported by patients taking Rexulti. The drug is made by Otsuka Pharmaceutical Company Ltd. in Japan.

    Like other schizophrenia drugs, Rexulti has a boxed warning about an increased risk of death associated with unapproved use of the drugs to treat behavioral problems in people with dementia-related psychosis.

    The boxed warning also cautions about an increased risk of suicidal thoughts and behavior in children, teens and young adults taking antidepressants. People taking the drug should be monitored for the start or worsening of suicidal thoughts and behavior, the FDA said.

    Today on WebMD

    vincent van gogh
    Famous faces you may recognize.
    paranoia
    Be aware of these warning signs.
     
    man with blurred face
    The real truth on this condition.
    dreamy psychodelic house and trees
    Types and causes.
     
    vincent van gogh
    Article
    paranoia
    Slideshow
     
    Schizophrenia What Increases Your Risk
    Article
    mother and daughter
    Article
     
    boy hiding under blanket
    Article
    male patient with doctor
    Article
     
    romantic couple
    Article
    businesswoman working at desk at night
    Article